Buscar
Mostrando ítems 1-7 de 7
Triple GLP-1/GIP/glucagon receptor agonists, a potential novel treatment strategy in Alzheimer’s disease (2020)
(Taylor and Francis Ltd, 2019)
A metabolic perspective of late onset Alzheimer's disease (2020)
(Academic Press, 2019)
Masitinib for the treatment of mild to moderate Alzheimer's disease (2020)
(Expert Reviews Ltd., 2015)
Excitotoxicity in the pathogenesis of neurological and psychiatric disorders: Therapeutic implications (2020)
(SAGE Publications Ltd, 2018)